3-Nitrocoumarin

CAS No. 28448-04-6

3-Nitrocoumarin( —— )

Catalog No. M32749 CAS No. 28448-04-6

3-Nitrocoumarin (3-nitrochromen-2-one) (3-NC) is a potent and selective Phospholipase C-γ (PLCγ) inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 55 In Stock
2MG 31 In Stock
5MG 49 In Stock
10MG 85 In Stock
25MG 173 In Stock
50MG 296 In Stock
100MG 423 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3-Nitrocoumarin
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Nitrocoumarin (3-nitrochromen-2-one) (3-NC) is a potent and selective Phospholipase C-γ (PLCγ) inhibitor.
  • Description
    3-Nitrocoumarin (3-NC) is a potent and selective Phospholipase C-γ (PLC-γ) inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Phospholipase
  • Recptor
    Phospholipase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28448-04-6
  • Formula Weight
    191.14
  • Molecular Formula
    C9H5NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 100 mg/mL (523.18 mM)
  • SMILES
    [O-][N+](=O)c1cc2ccccc2oc1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ward PD, et al. Phospholipase C-gamma modulates epithelial tight junction permeability through hyperphosphorylation of tight junction proteins. J Biol Chem. 2002 Sep 20;277(38):35760-5.?
molnova catalog
related products
  • Uric Acid

    An oxidation product, via xanthine oxidase, of oxypurines such as xanthine and hypoxanthine.

  • DPTIP

    DPTIP is an effective inhibitor of neutral sphingomyelinase 2 with an IC50 value of 30 nM.

  • Efipladib

    Efipladib (PLA 902) is a potent, selective and orally active inhibitor of cPLA2α with IC50 of 20 nM for LTB4 inhibition.